4CPS-190 Analysis of ibrutinib dose reduction in patients diagnosed with chronic lymphocytic leukaemia: are we doing it right?

Autor:	J Boo Rodríguez, A Ros Olaso, I Beristain Aramendi, A Eceiza Díez, A Latasa Berasategui, C Saiz Martínez, MJ Garcia de Andoin Barandiaran, J Landa Alberdi, D García Echeverría, G Lizeaga Cundin
Rok vydání:	2023
Zdroj:	Section 4: Clinical pharmacy services.
DOI:	10.1136/ejhpharm-2023-eahp.181
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::71075693921b1cc5191cc37d9b4cc993 https://doi.org/10.1136/ejhpharm-2023-eahp.181 Zobrazit plný text záznamu